Stifel Nicolaus analyst Mark Astrachan maintained a Hold rating on Colgate-Palmolive (CL – Research Report) today and set a price target of ...

Colgate-Palmolive Company CL shares have appreciated 13.1% in the trailing 12 months, outperforming the Zacks Consumer ...

Procter & Gamble and Colgate-Palmolive are among the defendants in six new lawsuits targeting the sale of toothpaste and ...

There is more to the comparison, and in the sections below, we discuss why we think CL will outperform KMB in the next three ...

Six class action complaints accuse major dental product makers of deceptively marketing products containing fluoride to young ...

Barclays analyst Lauren Lieberman maintained a Hold rating on Colgate-Palmolive (CL – Research Report) today and set a price target of $83.00.

We recently published a list of 10 Best Dividend Kings Stocks to Invest in Now. In this article, we are going to take a look ...

Investing in Dividend Kings is a reliable way to grow your passive income stream over time. When the S&P 500 is roaring ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Pallas Capital Advisors LLC lowered its position in Colgate-Palmolive (NYSE:CL – Free Report) by 6.6% in the 4th quarter, ...

Colgate-Palmolive (NYSE:CL – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the twenty-two ...

New York-based Colgate-Palmolive Company (CL) is a global leader in the oral care hygiene market. It produces and distributions household, healthcare and personal care products. With a market cap ...